Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China
Feng Sun,Wei Liu,Jing Wu,Ning Jiang,Qiao-ling Ruan,Qing-luan Yang,Yao-jie Shen,Jing-yu Zhou,Ling-yun Shao,Wen-hong Zhang
DOI: https://doi.org/10.1016/j.cmi.2021.09.022
IF: 13.31
2022-05-01
Clinical Microbiology and Infection
Abstract:ObjectivesPost-treatment recurrence remains a challenge for the global control of tuberculosis (TB). This study investigated longitudinal data on pulmonary TB recurrence rates and its risk factors among successfully treated smear-positive tuberculosis cases in China.MethodsFrom 1 January 2009 to 31 December 2016, we evaluated 33,441 treatment-naïve patients diagnosed with sputum smear-positive, non-multidrug-resistant TB in Hangzhou, China. We included the data of 9,828 patients with TB who were successfully treated.ResultsA total of 4.9% were recurrent cases (479/9,828), identified within a median observation period lasting 1,565 days. Altogether, 51.1% (245/479) of the recurrences occurred within one year. The cumulative 2- and 5-year recurrence rates were 3.90% (95% confidence interval [CI], 3.3%–4.5%) and 5.4% (95% CI, 4.8%–6.0%), respectively. Prolonged treatment (over 7 months) was occurred in 64.7% (6,363/9,828), with median treatment duration of 242 (interquartile range, 195–348) days. Male sex (adjusted hazard ratio [aHR] [95% CI] = 1.61 [1.30–2.00], P<0.001), ≥ 60-years age (aHR [95% CI] = 2.03 [1.70-2.44], P<0.001), pulmonary cavity (aHR [95% CI] = 1.51 [1.25–1.82], P<0.001) and sputum positive at 2 months (aHR [95% CI] =1.39 [1.05–1.81], P=0.02) increased the risk of TB recurrence. Prolonged treatment was associated with reduced TB recurrence (aHR [95% CI] =0.73 [0.61–0.88], P=0.001).ConclusionsRecurrence remains a problem for successfully treated patients with sputum smear-positive pulmonary TB, especially those with independent risk factors. Further analysis of prolonged treatment is required.
infectious diseases,microbiology